We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.3M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$78.9M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$77.4M
4
AAPL icon
Apple
AAPL
+$77M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$70.1M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NATR icon
2851
Nature's Sunshine
NATR
$288M
$231K ﹤0.01%
15,765
+980
+7% +$16.5K
INDT
2852
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$231K ﹤0.01%
3,299
+187
+6% +$12.8K
AQB icon
2853
AquaBounty Technologies
AQB
$6.02M
$230K ﹤0.01%
2,823
+82
+3% +$7.68K
MELI icon
2854
Mercado Libre
MELI
$92.3B
$230K ﹤0.01%
137
+1
+0.7% +$1.73K
ONCT
2855
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$230K ﹤0.01%
2,764
+69
+3% +$5.71K
EYPT icon
2856
EyePoint Inc
EYPT
$1.2B
$229K ﹤0.01%
22,014
+1,365
+7% +$13K
TBHC
2857
DELISTED
The Brand House Collective
TBHC
$229K ﹤0.01%
11,923
+630
+6% +$12.4K
PSTX
2858
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$229K ﹤0.01%
31,443
+982
+3% +$8.43K
NODK icon
2859
NI Holdings
NODK
$320M
$228K ﹤0.01%
12,978
-115
-0.9% -$2.2K
INST
2860
DELISTED
Instructure Holdings, Inc.
INST
$228K ﹤0.01%
+10,101
New +$215K
RGS icon
2861
Regis Corp
RGS
$70.2M
$227K ﹤0.01%
3,266
-531
-14% -$69.7K
TXMD icon
2862
TherapeuticsMD
TXMD
$24M
$226K ﹤0.01%
6,100
+398
+7% +$17.7K
ONIT
2863
Onity Group
ONIT
$332M
$226K ﹤0.01%
8,042
+228
+3% +$6.3K
LOTZ
2864
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$226K ﹤0.01%
59,308
+12,040
+25% +$51.9K
IMDX
2865
Insight Molecular Diagnostics
IMDX
$156M
$224K ﹤0.01%
3,149
-207
-6% -$19K
AQN icon
2866
Algonquin Power & Utilities
AQN
$4.42B
$223K ﹤0.01%
15,240
+28
+0.2% +$432
CDZI icon
2867
Cadiz
CDZI
$291M
$223K ﹤0.01%
31,729
+925
+3% +$11.4K
KVHI icon
2868
KVH Industries
KVHI
$157M
$222K ﹤0.01%
23,036
+5
+0% +$54
VOXX
2869
DELISTED
VOXX International Corporation Class A
VOXX
$222K ﹤0.01%
19,345
+85
+0.4% +$972
BBCP icon
2870
Concrete Pumping Holdings
BBCP
$491M
$221K ﹤0.01%
25,899
-65
-0.3% -$546
BH icon
2871
Biglari Holdings Class B
BH
$1.21B
$221K ﹤0.01%
1,286
-95
-7% -$16K
AWH
2872
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$221K ﹤0.01%
4,527
+155
+4% +$9.58K
CTXR icon
2873
Citius Pharmaceuticals
CTXR
$18.7M
$219K ﹤0.01%
4,317
+156
+4% +$7.83K
IPSC icon
2874
Century Therapeutics
IPSC
$361M
$219K ﹤0.01%
+8,697
New +$235K
BCEL
2875
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$218K ﹤0.01%
34,959
+834
+2% +$5.56K
113 114
115
116 117

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.